返回ChemicalBook首页>CAS数据库列表>82101-17-5

82101-17-5

中文名称 伊普柳氮
英文名称 ipsalazide
CAS 82101-17-5
MOL 文件 82101-17-5.mol
82101-17-5 结构式 82101-17-5 结构式

基本信息

中文别名
化合物 T19379
英文别名
5-(Carboxymethylcarbamoyl-4-phenylazo)salicylic acid (disodium)
5-[[4-[(Sodiooxycarbonylmethyl)carbamoyl]phenyl]azo]-2-hydroxybenzoic acid sodium salt
Benzoic acid, 5-((4-(((carboxymethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium salt

物理化学性质

储存条件-20°C储存
溶解度溶于二甲基亚砜

常见问题列表

生物活性
Ipsalazide 是一种新的柳氮磺吡啶类似物,旨在释放胃肠道中的 5-氨基水杨酸和无毒载体分子。
体外研究

Sulfasalazine exerts beneficial effects in colitis by releasing 5-aminosalicylic acid in the colon, but its use can be limited by side effects. Ipsalazide is designed which the sulfapyridine of sulfasalazine has been replaced by carrier molecules.

体内研究

No deaths or visible abnormalities occurrs within 7 days of a single oral dose of ipsalazide (4 g/kg in mice or 2 g/kg in rats). No abnormalities were seen at postmortem. The ipsalazide carrier molecule (ABG) is readily absorbed, with nearly half of the dose appearing in the urine. However, around 40% of the ABG was not recovered, and it is possible that this has undergone further metabolism, with loss of the aromatic amine function which is the basis for the colorimetric measurement of ABG.

"82101-17-5" 相关产品信息